Fresenius Medical Care AG & Co. (Pref) (FME) Given a €92.00 Price Target by Citigroup Analysts

Fresenius Medical Care AG & Co. (Pref) (ETR:FME) received a €92.00 ($113.58) price target from Citigroup in a research note issued to investors on Monday. The firm presently has a “buy” rating on the stock. Citigroup’s price objective suggests a potential upside of 7.40% from the stock’s previous close.

Several other equities analysts have also recently weighed in on FME. Deutsche Bank set a €83.00 ($102.47) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a research note on Friday, October 20th. JPMorgan Chase & Co. set a €95.40 ($117.78) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Friday, October 20th. Berenberg Bank set a €95.60 ($118.02) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Tuesday, October 24th. Goldman Sachs Group set a €97.00 ($119.75) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Monday, October 30th. Finally, Commerzbank set a €87.00 ($107.41) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a research note on Thursday, November 2nd. Eleven equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Fresenius Medical Care AG & Co. (Pref) currently has an average rating of “Hold” and an average target price of €90.96 ($112.30).

Fresenius Medical Care AG & Co. (FME) opened at €85.66 ($105.75) on Monday. Fresenius Medical Care AG & Co. has a 52 week low of €75.53 ($93.25) and a 52 week high of €93.82 ($115.83). The firm has a market cap of $25,940.00 and a price-to-earnings ratio of 21.00.

TRADEMARK VIOLATION WARNING: “Fresenius Medical Care AG & Co. (Pref) (FME) Given a €92.00 Price Target by Citigroup Analysts” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/02/12/fresenius-medical-care-ag-92-00-price-target-by-citigroup-analysts.html.

About Fresenius Medical Care AG & Co. (Pref)

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply